Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase

被引：128

作者：

Heerding, Dirk A. ^{[1
]}

Rhodes, Nelson ^{[1
]}

Leber, Jack D. ^{[1
]}

Clark, Tammy J. ^{[1
]}

Keenan, Richard M. ^{[1
]}

Lafrance, Louis V. ^{[1
]}

Li, Mei ^{[1
]}

Safonov, Igor G. ^{[1
]}

Takata, Dennis T. ^{[1
]}

Venslavsky, Joseph W. ^{[1
]}

Yamashita, Dennis S. ^{[1
]}

Choudhry, Anthony E. ^{[1
]}

Copeland, Robert A. ^{[1
]}

Lai, Zhihong ^{[1
]}

Schaber, Michael D. ^{[1
]}

Tummino, Peter J. ^{[1
]}

Strum, Susan L. ^{[1
]}

Wood, Edgar R. ^{[1
]}

Duckett, Derek R. ^{[1
]}

Eberwein, Derek ^{[1
]}

Knick, Victoria B. ^{[1
]}

Lansing, Timothy J. ^{[1
]}

McConnell, Randy T. ^{[1
]}

Zhang, ShuYun ^{[1
]}

Minthorn, Elisabeth A. ^{[1
]}

Concha, Nestor O. ^{[1
]}

Warren, Gregory L. ^{[1
]}

Kumar, Rakesh ^{[1
]}

机构：

[1] GlaxoSmithKline, Oncol Ctr Excellence Drug Discovery, Collegeville, PA 19426 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 18期

关键词：

D O I：

10.1021/jm8004527

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Overexpression of AKT has an antiapoptotic effect in many cell types, and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival. Therefore, inhibitors of AKT kinase activity might be useful as monotherapy for the treatment of tumors with activated AKT. Herein, we describe our lead optimization studies cultriinating in the discovery of compound 3g (GSK690693). Compound 3g is a novel ATP competitive, pan-AKT kinase inhibitor with IC50 values of 2, 13, and 9 nM against AKT1, 2, and 3, respectively. An X-ray cocrystal structure was solved with 3g and the kinase domain of AKT2, confirming that 3g bound in the ATP binding pocket. Compound 3g potently inhibits intracellular AKT activity as measured by the inhibition of the phosphorylation levels of GSK3 beta. Intraperitoneal administration of 3g in immunocompromised mice results in the inhibition of GSK3 beta phosphorylation and tumor growth in human breast carcinoma (BT474) xenografts.

引用

页码：5663 / 5679

页数：17

共 50 条

[21] 1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors' (vol 15, pg 3402, 2005)
Bamford, Mark J.
Alberti, Michael J.
Bailey, Nicholas
Davies, Susannah
Dean, David K.
Gaiba, Alessandra
Garland, Stephen
Harling, John D.
Jung, David K.
Panchal, Terence A.
Parr, Christopher A.
Steadman, Jon G.
Takle, Andrew K.
Townsend, James T.
Wilson, David M.
Witherington, Jason
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (05) : 1151 - 1151
[22] ZnII and CuII complexes generated from 5-(pyridin-4-yl)-3-[2-(pyridin-4-yl)ethyl]-1,3,4-oxadiazole-2(3H)-thione
Zhao, Hang-Ju
Ma, Jian-Ping
Liu, Qi-Kui
Dong, Yu-Bin
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2013, 69 : 716 - +
[23] REARRANGEMENT OF ETHYL 2-(3-AMINO-4-PYRIDINYL)HYDRAZINECARBOXYLATE HYDROCHLORIDE TO 1-AMINO-1H-IMIDAZO[4,5-C]PYRIDIN-2(3H)ONE HYDROCHLORIDE
WRIGHT, GC
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1976, 13 (03) : 601 - 603
[24] Synthesis and transformations of 4-amino-4′-(4-nitro-1H-1,2,3-tri-azol-1-yl)- and 4-amino-4′-(1,2,3-triazolo[4,5-c]-1,2,5-oxadiazol-5-yl)- 3,3′-(NNO)-azoxy-1,2,5-oxadiazoles
L. V. Batog
V. Yu. Rozhkov
E. V. Shatunova
M. I. Struchkova
Russian Chemical Bulletin, 2008, 57 : 165 - 169
[25] 2-[4,5-Diphenyl-2-(pyridin-2-yl)-1H-imidazol-1-yl]-3-phenylpropan-1-ol
Yang, Liangru
Xiao, Yongmei
He, Kun
Yuan, Jinwei
Mao, Pu
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1670 - +
[26] N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
Korlyukov, Alexander A.
Dorovatovskii, Pavel V.
Vologzhanina, Anna V.
MOLBANK, 2022, 2022 (04)
[27] 2-[2-Methyl-5-phenyl-1-(3,4,5-trimethoxyphenyl)-1H-pyrrol-3-yl]-2-oxo-N-(pyridin-4-yl) acetamide
Moghadam, Ebrahim Saeedian
Amini, Mohsen
MOLBANK, 2018, (03)
[28] Synthesis and Reactivity of Azidoximes: III. 1-Azido(4-amino-1,2,5-oxadiazol-3-yl)aldoxime in the Cycloaddition Reaction
T. V. Romanova
S. F. Mel'nikova
I. V. Tselinskii
Russian Journal of Organic Chemistry, 2003, 39 : 574 - 578
[29] Design, Synthesis, Molecular Docking and Biological Evaluation of Novel 2-[(2-{[5-(Pyridin-4-yl)-1, 3, 4-Oxadiazol-2-yl]Sulfanyl}Ethyl)Sulfanyl]-1,3-Benzoxazole
Fathima, Anees
Vagdevi, H. M.
Jayanna, N. D.
Shafeeulla, R. Mohammed
Subbaraju
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (44A) : 472 - 484
[30] Synthesis and reactivity of azidoximes: III. 1-azido(4-amino-1,2,5-oxadiazol-3-yl)aldoxime in the cycloaddition reaction
Romanova, TV
Mel'nikova, SF
Tselinskii, IV
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2003, 39 (04) : 574 - 578

← 1 2 3 4 5 →